Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eporgen Venture is an Italian seed capital company and biotech incubator focused on the development of innovative therapeutic and diagnostic projects. Founded in 2004 and headquartered in the Bioindustry Park Silvano Fumero, the company operates by identifying high-potential research from Italian academia and transforming it into viable biotech startups. Eporgen provides both financial backing and management expertise to its portfolio companies, guiding them through the early stages of drug discovery and development. Its portfolio has included companies working on diverse indications such as oncology, respiratory diseases, and rare blood disorders. Notable successes include the incubation of EryDel and Kither Biotech, which have advanced programs into late-stage clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eporgen Venture.